Mosaic ImmunoEngineering, Inc.
CPMV
$0.98
$0.27839.60%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -23.48% | -21.73% | -39.44% | -38.93% | -40.17% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -38.03% | -38.12% | -48.74% | -46.73% | -45.11% |
Operating Income | 38.03% | 38.12% | 48.74% | 46.73% | 45.11% |
Income Before Tax | 14.45% | -13.73% | 55.37% | 57.71% | 53.82% |
Income Tax Expenses | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% |
Earnings from Continuing Operations | 14.61% | -13.47% | 55.48% | 57.65% | 53.78% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 14.61% | -13.47% | 55.48% | 57.65% | 53.78% |
EBIT | 38.03% | 38.12% | 48.74% | 46.73% | 45.11% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | 14.63% | -13.57% | 55.46% | 57.66% | 53.78% |
Normalized Basic EPS | 35.47% | 32.84% | 47.30% | 46.10% | 44.43% |
EPS Diluted | 14.41% | -15.59% | 54.07% | 56.47% | 53.07% |
Normalized Diluted EPS | 33.36% | 30.83% | 49.51% | 48.07% | 46.19% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.01% | 0.01% | 0.03% |
Average Diluted Shares Outstanding | -4.40% | -4.40% | 4.61% | 4.62% | 4.64% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |